106 related articles for article (PubMed ID: 30889003)
21. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
Head Neck; 2016 Apr; 38(4):E76-80. PubMed ID: 26275126
[TBL] [Abstract][Full Text] [Related]
22. Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours.
Kembhavi SA; Rangarajan V; Shah S; Qureshi S; Arora B; Juvekar S; Laskar S; Vora T; Chinnaswamy G; Ramadwar M; Kurkure P
Clin Radiol; 2014 Sep; 69(9):900-8. PubMed ID: 24863003
[TBL] [Abstract][Full Text] [Related]
23. Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors.
Abdulrezzak U; Kurt YK; Kula M; Tutus A
Nucl Med Commun; 2016 Aug; 37(8):874-81. PubMed ID: 27096719
[TBL] [Abstract][Full Text] [Related]
24. 68Ga-DOTA-TOC Uptake in Pleomorphic Adenoma.
Laurens ST; Netea-Maier RT; Aarntzen EJHG
Clin Nucl Med; 2018 Jul; 43(7):524-525. PubMed ID: 29847321
[TBL] [Abstract][Full Text] [Related]
25. Semiquantitative analysis and characterization of physiological biodistribution of (68)Ga-DOTA-TATE PET/CT.
Kunikowska J; Królicki L; Pawlak D; Zerizer I; Mikołajczak R
Clin Nucl Med; 2012 Nov; 37(11):1052-7. PubMed ID: 22996234
[TBL] [Abstract][Full Text] [Related]
26. (18)F-FDG PET as a single imaging modality in pediatric neuroblastoma: comparison with abdomen CT and bone scintigraphy.
Choi YJ; Hwang HS; Kim HJ; Jeong YH; Cho A; Lee JH; Yun M; Lee JD; Kang WJ
Ann Nucl Med; 2014 May; 28(4):304-13. PubMed ID: 24481823
[TBL] [Abstract][Full Text] [Related]
27. Combined 18F-FDG PET/CT and 68Ga DOTATATE PET/CT "Superscan" in Metastatic Pancreatic Neuroendocrine Tumor.
Chan M; Schembri GP
Clin Nucl Med; 2017 Feb; 42(2):108-109. PubMed ID: 27997429
[TBL] [Abstract][Full Text] [Related]
28. Detection of Metastatic Meningioma to the Liver Using 68Ga-DOTA-Octreotate PET/CT.
Villanueva-Meyer JE; Magill ST; Lee JC; Umetsu SE; Flavell RR
Clin Nucl Med; 2018 Sep; 43(9):e338-e340. PubMed ID: 29939957
[TBL] [Abstract][Full Text] [Related]
29. 68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Epithelioid Hemangioendothelioma: Comparison With 18F-FDG.
Derlin T; Hueper K; Soudah B
Clin Nucl Med; 2017 Nov; 42(11):e478-e479. PubMed ID: 28872546
[TBL] [Abstract][Full Text] [Related]
30. Giant Cell Tumor of Tendon Sheath Revealed on 68Ga-DOTA-TATE PET/CT in a Patient With Suspicious Tumor-Induced Osteomalacia.
Jia C; Shao F; Yang M; Qin C; Lan X
Clin Nucl Med; 2019 Jun; 44(6):496-498. PubMed ID: 30932980
[TBL] [Abstract][Full Text] [Related]
31. 99mTc-LLEC Renal Dynamic Scan in a Patient With Pelvic Neuroblastoma.
Konudula SR; L P; Ponnusamy M; H D; Pandit N
Clin Nucl Med; 2019 May; 44(5):406-407. PubMed ID: 30762826
[TBL] [Abstract][Full Text] [Related]
32. Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma.
Kong G; Hofman MS; Murray WK; Wilson S; Wood P; Downie P; Super L; Hogg A; Eu P; Hicks RJ
J Pediatr Hematol Oncol; 2016 Mar; 38(2):87-96. PubMed ID: 26296147
[TBL] [Abstract][Full Text] [Related]
33. 68Ga-DOTATOC and FDG PET Imaging of Preclinical Neuroblastoma Models.
Provost C; Prignon A; Cazes A; Combaret V; Delattre O; Janoueix-Lerosey I; Montravers F; Talbot JN
Anticancer Res; 2016 Sep; 36(9):4459-66. PubMed ID: 27630282
[TBL] [Abstract][Full Text] [Related]
34. 18F-FDG PET/CT and 123I-metaiodobenzylguanidine imaging in high-risk neuroblastoma: diagnostic comparison and survival analysis.
Papathanasiou ND; Gaze MN; Sullivan K; Aldridge M; Waddington W; Almuhaideb A; Bomanji JB
J Nucl Med; 2011 Apr; 52(4):519-25. PubMed ID: 21421719
[TBL] [Abstract][Full Text] [Related]
35. Improvement in diagnosis of metastatic pituitary carcinoma by 68Ga DOTATATE PET/CT.
Xiao J; Zhu Z; Zhong D; Ma W; Wang R
Clin Nucl Med; 2015 Feb; 40(2):e129-31. PubMed ID: 24873798
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
Dhull VS; Sharma P; Patel C; Kundu P; Agarwala S; Bakhshi S; Bhatnagar V; Bal C; Kumar R
Nucl Med Commun; 2015 Oct; 36(10):1007-13. PubMed ID: 26049371
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.
Li C; Zhang J; Chen S; Huang S; Wu S; Zhang L; Zhang F; Wang H
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):306-315. PubMed ID: 29110068
[TBL] [Abstract][Full Text] [Related]
38. 68Ga-DOTA-TATE PET/CT imaging for differentiating a sarcoid-like reaction from progression following immunotherapy in a triple-negative breast carcinoma patient.
Deleu AL; Hanssens M; Maes A; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):945-946. PubMed ID: 32794106
[No Abstract] [Full Text] [Related]
39. Abnormal FDG and MIBG Activity in the Bones in a Patient With Neuroblastoma Without Detectable Primary Tumor.
Zhang W; Zhuang H; Servaes S
Clin Nucl Med; 2016 Aug; 41(8):632-3. PubMed ID: 26825196
[TBL] [Abstract][Full Text] [Related]
40. Brain Metastases of a Neuroendocrine Tumor Visualized by 68Ga-DOTATATE PET/CT.
Hoberück S; Michler E; Zöphel K; Platzek I; Kotzerke J; Brogsitter C
Clin Nucl Med; 2019 Jan; 44(1):50-52. PubMed ID: 30371585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]